Hyperphosphatemia

Novel Tool May Help Dialysis Patients with Phosphorus Control

Jody A. Charnow April 30, 2011

LAS VEGAS—A novel interactive Web-based phosphorus education tool may help to improve phosphorus control in dialysis patients, according to a report at the National Kidney Foundation's Spring Clinical Meetings.

Hyperphosphatemia and Anemia Risk Factors in Diabetic Nephropathy Patients

Jody A. Charnow April 30, 2011

LAS VEGAS—Albumunuria, proteinuria, lower estimated glomerular filtration rate (eGFR) in patients with diabetic nephropathy are significantly associated with hyperphosphatemia and anemia, researchers reported at the National Kidney Foundation's Spring Clinical Meetings.

Study Finds No Link Between FGF-23 and Dietary Phosphorus

Jody A. Charnow April 29, 2011

LAS VEGAS—Fibroblast growth factor 23 (FGF-23) is not significantly associated with dietary phosphorus or urinary phosphorus excretion, researchers reported at the National Kidney Foundation's Spring Clinical Meetings.

Lanthanum Carbonate Found to Bind Dietary Phosphorus Better than Sevelamer

Jody A. Charnow April 28, 2011

LAS VEGAS—Lanthanum carbonate binds dietary phosphorus more effectively than sevelamer, researchers reported here at the National Kidney Foundation's Spring Clinical Meetings.

CKD Stage 3 Patients Benefit from Extended-Release Niacin

Jody A. Charnow April 28, 2011

LAS VEGAS—New findings presented at the National Kidney Foundation's Spring Clinical Meetings confirm the phosphorus-lowering effects of extended-release niacin in fixed-dose combination with laropiprant (ERN-L) in dyslipidemic patients with stage 3 chronic kidney disease (CKD).

Crushed Lanthanum Carbonate an Option for HD Patients

Jody A. Charnow March 14, 2011

Crushing lanthanum carbonate and mixing it with food can be an option for hemodialysis (HD) patients with hyperphosphatemia who are unable to chew or swallow whole tablets, researchers reported in Hemodialysis International (2011;15:95-99).

Novel Binder Lowers Phosphorus, LDL Cholesterol

Jody A. Charnow January 24, 2011

An investigational calcium-free phosphate binder called colestilan is safe and effective for controlling phosphorus in dialysis patients, and it has no impact on calcium levels, researchers reported.

Parathyroid Hormone, Alkaline Phosphatase and Fibroblast Growth Factor 23

By Orlando M. Gutiérrez, MD January 01, 2011

The management of chronic kidney disease-mineral bone disorder (CKD-MBD) is central to the care of patients with kidney disease. Key to these efforts is the availability of clinically accessible biomarkers that can help distinguish between a wide variety of bone and mineral disturbances related to kidney failure.

Restricting Dietary Phosphate Confers No Survival Benefit

Tasheema Prince December 10, 2010

Prescribed dietary phosphate restriction, as practiced today, is not associated with improved survival among hemodialysis (HD) patients, according to a new study. In fact, it may even increase the risk of death.

Phosphate-Binder Treatment May Lower Mortality

Delicia Honen Yard October 19, 2010

Phosphate-binder therapy is associated with reduced mortality in men with non-dialysis-dependent CKD, a study found.

Chewing Gum Could Aid in Phosphorus Control

Alison Steiber, PhD, RD, LD October 11, 2010

Chitosan gum could offer dialysis patients an inexpensive way to control phosphorus nonsystemically without adding to their daily pill burden.

Lanthaum Carbonate Better for Phosphorus Absorption

Jody A. Charnow July 27, 2010

Mean net dietary phosphorus absorption is significantly lower after a single dose of lanthanum carbonate (LC) than after a single dose of sevelamer carbonate (SC), data suggest.

Phosphate Binder May Reduce the Number of Hospitalization Days

Jody A. Charnow April 17, 2010

Using sevelamer instead of calcium-based binders (CBBs) to treat hyperphosphatemia in dialysis patients can significantly decrease the number of days of hospitalization, shows a new analysis presented at the National Kidney Foundation's 2010 Spring Clinical Meetings. .

Sevelamer Carbonate May Impair Calcitriol Bioavailability

Jody A. Charnow April 17, 2010

Sevelamer carbonate significantly decreases the bioavailability of oral calcitriol when the two drugs are administered together, but lanthanum carbonate does not, show data presented at the National Kidney Foundation's 2010 Spring Clinical Meetings.

Fluid Intake with Phosphate Binders Quantified

Jody A. Charnow April 17, 2010

The daily fluid intake with phosphate binder (PB) pills accounts for a significant portion of the daily fluid restriction in hemodialysis (HD) patients, suggest data presented at the National Kidney Foundation's 2010 Spring Clinical Meetings.

CKD Incidence Higher in African Americans Than Whites

Renal Function Decline Often Precedes Macroalbuminuria in Type 2 Diabetes

Myocardial Infarctions Frequently Unrecognized in Kidney Disease Patients

Severe Vitamin D Deficiency Raises Death Risk in Hemodialysis Patients

Let Patients Sleep During Rounds

Antibiotic Lock Reduces Catheter-Related Problems

Our exclusive coverage of Kidney Week 2011 in Philadelphia includes interviews, videos and noteworthy clinical reports.

Sections: Anemia | Transplantation
Secondary Hyperparathyroidism | General News
More: Videos

On The Forefront

Boosting Renal Transplantation with Kidney Paired Donation

In the past five to 10 years, researchers have developed several techniques to overcome donor incompatibility, including paired donation. The following case illustrates the collaborative efforts between nephrologists and urologists at the Glickman Urological and Kidney Institute.